These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 27214983)

  • 1. [INSULIN-LIKE GROWTH FACTOR-1: THE INFLUENCE ON THE LIVER FUNCTION AND RELATIONSHIPS WITH RESISTIN IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND ITS COMBINATION WITH TYPE 2 DIABETES MELLITUS].
    Zhuravlyova LV; Ogneva EV; Zhuravlyova AK
    Eksp Klin Gastroenterol; 2015; (11):23-7. PubMed ID: 27214983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adipokines and liver function in patients with nonalcoholic fatty liver disease, type 2 diabetes mellitus and its combination].
    Zhuravleva LV; Ogneva EV
    Eksp Klin Gastroenterol; 2014; (8):21-6. PubMed ID: 25911908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
    Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
    Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
    Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores.
    Senateş E; Colak Y; Yeşil A; Coşkunpinar E; Sahin O; Kahraman OT; Erkalma Şenateş B; Tuncer I
    Minerva Med; 2012 Oct; 103(5):369-76. PubMed ID: 23042372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.
    Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of resistin in the liver of patients with non-alcoholic fatty liver disease.
    Gierej P; Gierej B; Kalinowski P; Wróblewski T; Paluszkiewicz R; Kobryń K; Ziarkiewicz-Wróblewska B
    Pol J Pathol; 2017; 68(3):225-233. PubMed ID: 29363914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai.
    Chanchay S; Tungtrongchitr R; Harnroongroj T; Phonrat B; Rungseesakorn O; Paksanont S; Pooudong S; Saowakontha S; Varongchayakul C
    Int J Vitam Nutr Res; 2006 May; 76(3):125-31. PubMed ID: 17048191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.
    Pagano C; Soardo G; Pilon C; Milocco C; Basan L; Milan G; Donnini D; Faggian D; Mussap M; Plebani M; Avellini C; Federspil G; Sechi LA; Vettor R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1081-6. PubMed ID: 16394091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
    Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM
    Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum resistin levels in patients with type 2 diabetes mellitus and its relationship with body composition.
    Habib SS
    Saudi Med J; 2012 May; 33(5):495-9. PubMed ID: 22588809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
    Zhang XJ; Wang Z; Li HH; Yu L; Gao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological aspects of liver under variable food restriction: has the intense one-week food restriction a protective effect on non-alcoholic-fatty-liver-disease (NAFLD) development?
    Makovicky P; Tumova E; Volek Z; Makovicky P; Vodickova L; Slyskova J; Svoboda M; Rejhova A; Vodicka P; Samasca G; Kralova A; Nagy M; Mydlarova-Blascakova M; Poracova J
    Pathol Res Pract; 2014 Dec; 210(12):855-62. PubMed ID: 25238938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system.
    Dalamaga M; Karmaniolas K; Nikolaidou A; Chamberland J; Hsi A; Dionyssiou-Asteriou A; Mantzoros CS
    Eur J Cancer; 2008 Aug; 44(12):1744-53. PubMed ID: 18515085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.